deals, Life Sciences, HIV
Panacos Sells HIV Drug for $7M
Ryan McBride 1/21/09
Watertown, MA-based Panacos Pharmaceuticals (NASDAQ:PANC) says it has sold its lead HIV drug candidate, bevirimat, to Myriad Pharmaceuticals of Salt Lake City for $7 million. Panacos, a developer of antiviral drugs, said it would seek financing options late last year when it disclosed that it agreed to early repayment of a $20 million loan to lender Hercules Technology Growth Capital.
Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.
